Oscar Health (OSCR, Financial) announced impressive financial results for the first quarter, surpassing market expectations. The company's revenue reached $3.05 billion, significantly exceeding the anticipated $2.87 billion. This strong financial performance highlights continued growth both at the top and bottom lines, with notable year-over-year improvements in both revenue and net income.
The leadership at Oscar Health remains confident in achieving further margin expansion throughout the fiscal year. Their focus is on providing exceptional value to their members and partners, reinforcing their commitment to excellence and growth in the health insurance sector.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 9 analysts, the average target price for Oscar Health Inc (OSCR, Financial) is $18.28 with a high estimate of $28.00 and a low estimate of $8.00. The average target implies an upside of 39.85% from the current price of $13.07. More detailed estimate data can be found on the Oscar Health Inc (OSCR) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Oscar Health Inc's (OSCR, Financial) average brokerage recommendation is currently 2.8, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Oscar Health Inc (OSCR, Financial) in one year is $18.77, suggesting a upside of 43.61% from the current price of $13.07. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Oscar Health Inc (OSCR) Summary page.
